Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$593,610
+$575,505 QoQ
Shares Held
952
+4227.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#761
of 1,322 holders
Holding Since
Jun 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026L2 Asset Management, LLC holds $28,710,157 across 7 Biotechnology names. REGN ranks #5 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
129,324 | $7,251,196 | |
| 2 | INCY |
Incyte Corp
|
61,784 | $7,003,834 | |
| 3 | EXEL |
Exelixis, Inc.
|
125,702 | $6,839,445 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
27,290 | $6,576,071 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
952 | $593,610 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
768 | $231,191 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,147 | $214,810 |
All Filings in REGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $593,610 | 952 | Shares | Sole | 2026-08-13 | |
| 2023-09-30 | $18,105 | 22 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,115,892 | 1,553 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,598,969 | 1,946 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,001,428 | 1,388 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $956,151 | 1,388 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $581,671 | 984 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||